Beam Therapeutics Inc (BEAM)
$27.23 -5.58% Close Oct 30, 2026 Live
Beam Therapeutics stock today
Beam Therapeutics closed at $27.23 on October 30, 2026, down 5.58% on the day. Over the past year it returned +14.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.80 billion.
$20.00$30.00
NovJan 2026MarMayJulSep
| Period | BEAM | S&P 500 (SPY) |
|---|---|---|
| 1 month | +11.4% | -0.9% |
| 3 months | +2.8% | +2.1% |
| Year to date | -1.8% | +11.7% |
| 1 year | +14.4% | +12.4% |
| 3 years | +42.5% | +88.5% |
| 5 years | -69.3% | +76.0% |
Key statistics
- Market value
- $2.80B
- Price / sales
- 18.0
- 52-week range
- $20.60 to $37.92
- Next report
- Nov 3, 2026 (estimated)
About Beam Therapeutics
Develops base editing therapies to treat genetic and acquired diseases.
Sector: Health Care
More on Beam Therapeutics
- Financials: revenue, earnings and segmentsRevenue +120% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $306.75 today
No forecast, no recommendation. This page describes Beam Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.